Introduction
Fungi from the Mucorales order are abundant, ubiquitous, and saprophytic, with rapidly growing mycelium that are typically unseptate or irregularly septate. 1 Although important in the ecosystem, 2 they are lethal opportunistic fungal infections when encountered in persons who are immunocompromised. 3 Two main types of fungal infections of the skin may be present in immunocompromised patients with neutropenia: primary cutaneous fungal infections and cutaneous manifestations of fungemia. 4 We present a case of a 72-yearold, immunocompromised, neutropenic woman with aplastic anemia who developed primary cutaneous Rhizopus fungal infection on her right forearm following a bite from a household cat. The cutaneous fungal infection expanded and caused extensive necrotizing fasciitis of the entire extensor compartment of the patient's right forearm.
Case Report
A 72-year-old woman diagnosed with aplastic anemia received her first chemotherapy cycle of antithymocyte globulin, methylprednisolone, and cyclosporine in July 2013. She remained neutropenic for 3 weeks prior to being admitted to the hospital in August 2013. Following chemotherapy, she continued on prophylactic acyclovir and voriconazole while she concurrently received cyclosporine and weekly intravenous hydrocortisone 100 mg.
She presented with a flat, homogenous, circular, and nonerythematous lesion with a large black eschar (Fig 1) . She sustained a traumatic cat bite to the area approximately 5 days prior to her cycle of chemotherapy. The patient denied any fever, chills, or sweats. She was not dependent on packed red blood cell transfusions but did receive biweekly platelets. She had no history of hypoglycemic or iron-chelating agents. She was empirically started on cefepime, metronidazole, and azithromycin.
Her vital signs were within normal limits. Physical examination revealed a prominent 12 × 14 cm lesion with a large central eschar on her right forearm (see Fig 1) . Recent laboratory studies included a white blood cell count of 0.77/mm 3 , an absolute neutrophil count (ANC) of 70 cells/mm 3 , a platelet level of 63,000/mm 3 , and a creatinine level of 0.9 mg/dL. The results of liver function tests were within normal limits.
Punch biopsy from the histological section of the lesion on her forearm revealed multiple broad, hyposeptated hyphae in cross and longitudinal sections with abundant vascular invasion (Fig 2) . This was consistent with Zygomycetes fungi (Mucorales) infection. Treatment was modified to liposomal amphotericin B 5 mg/kg intravenously once daily and posaconazole 200 mg suspension 4 times a day via a gastrostomy tube. This antifungal regimen was started immediately, and the patient underwent prompt surgical evaluation.
The wound was extensively debrided (Fig 3) . The cutaneous fungal infection had invaded the entire forearm extensor compartment, including the skin, fat, fascia and underlying musculature, demonstrating significant necrosis. Thus, we determined that the wound would best be resolved with amputation of the extremity, which the patient and daughter both declined. The area was closed and a temporary skin allograft was applied (Fig 4) .
The patient and her family subsequently declined any further surgical intervention or treatment, and she was discharged home with hospice care. She died 2 days later. Debrided, nonviable tissue was positive for Rhizopus by both fungal stain and culture. Angiolymphatic invasion by Rhizopus was also seen on the pathology specimen. 
Literature Review
In the 51 cases identified, 66.7% were neutropenic on presentation and 54.9% were male (Table 1) . [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] All primary cutaneous mold infections in patients with hematological malignancy were caused by molds from 1 of 2 phylum, Zygomycota or Ascomycota (Fig 5) . [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Within the phylum Zygomycota, the following 5 genera/classes caused infections: Absidia, Mucorales, Rhizopus, Rhizomucor ("Other"), and Cunninghamella ("Other"; see Fig 5) . [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Within the phylum Ascomycota, the following 5 genera caused infections: Aspergillus, Alternaria, Fusarium, Acremonium, and Curvularia ("Other"; see Fig 5) . [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In patients with hematological malignancy and primary cutaneous mold infection, outcomes were determined on whether or not the infection was localized vs disseminated. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In cases in which the infection remained localized, 100% of patients recov- ered; by contrast, in cases of disseminated infection, the mortality rate was 29.4%.
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Discussion
Mucormycosis, also known as zygomycosis, phycomycosis, or hyphomycosis, is a broad term for a multitude of diseases caused by fungi in the Mucorales order, with the most common causative organism being of the Rhizopus species. 24 Other genera include, in descending order of prevalence, Rhizomucor, Cunninghamella, Apophysomyces, Saksenaea, Absidia, Mucor, Syncephalastrum, Cokeromyces, and Mortierella. 24, 25 Six clinical forms of mucormycosis have been described: rhinocerebral, cutaneous, pulmonary, disseminated, gastrointestinal, and miscellaneous. 26 The most common clinical presentation of mucormycosis is rhino-orbital-cerebral infection. 27 Severe neutropenia with an ANC of less than 500 cells/mm 3 increases susceptibility to bacterial or fungal infections. 28 Our patient's ANC was 70 cells/mm 3 , which predisposed her to developing cutaneous mucormycosis. It has been postulated that individuals who lack phagocytes or who have impaired phagocytic function are at higher risk of mucormycosis than their normal counterparts. 29 By contrast, patients with HIV/AIDS do not appear to be at increased risk for developing mucormycosis. 29 Therefore, neutrophils -but not necessarily T-cell lymphocytes -are critical for inhibiting fungal-spore proliferation. 29 Cutaneous mucormycosis is an increasingly prevalent form of mucormycosis that has been predominantly described in immunocompromised patients who are recipients of transplants, including both hematopoietic stem cell and solid organ transplants after minor trauma. 30, 31 Some studies suggest that the incidence of zygomycosis appears to be increasing in oncology centers and specifically in patient populations receiving hematopoietic stem cell transplants, possibly related to the use of voriconazole prophylaxis. 32 Penetrating trauma remains the major cause of primary cutaneous zygomycosis (Table 2) . [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Other causes reported include elasticized bandages 57 intravenous access, 58 and dog bite. 59 Our case report of primary cutaneous mucormycosis after a cat bite is a rare finding. Although it was not confirmed, we suspect that this patient's fungal infection may have resulted from the cat's mouth being contaminated with soil that contained Mucorales, because the patient did not recall having any other penetrating trauma. Zachary et al 59 suggest that, in canine flora, Mucor species is an atypical finding. Therefore, this could be true for a cat's oral flora. This case is noteworthy because we found no existing case reports of cutaneous mucormycosis following a cat bite.
The diagnosis may be difficult to make because these infectious lesions can be confused with ischemic pathology. 60 Mucormycosis relies on analyses of clinical samples by microscopy and culture. Recovery of Zygomycetes from tissue can be problematic, and fungal detection is often hindered by the absence of fungal growth in culture; therefore, the diagnosis is often delayed or made postmortem. Furthermore, Larché et al 61 and Nosari et al 62 proposed use of a molecular test to enable rapid identification of Mucorales at the genus and species levels.
Treatment consists of high doses of amphotericin B combined with aggressive surgery and correction of the immune deficits. Using lipid formulations of amphotericin B helps reduce nephrotoxicity and permits the administration of higher doses that may increase efficacy. [63] [64] [65] In spite of appropriate management, the mortality rate for cutaneous mucormycosis has been reported to be up to 16%. 66 The higher overall mortality rate of 29.4% seen in the review of the literature was observed more frequently in patients with neutropenia (60.0%) and without surgical intervention (73.3%), and the survival rate was higher (35.3%) for cases utilizing both antifungal and surgical interventions. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] The antifungal agent with the highest survival rate was amphotericin B and its formulations (58.8%).
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Conclusions
Neutropenia within the setting of hematological malignancies increases the risk for developing severe cutaneous fungal infections, of which primary cutaneous mucormycosis can carry significant mortality. Combination antifungal therapy and surgical debridement appear to be associated with higher survival outcomes and, thus, this treatment plan warrants further investigation.
